- Report
- February 2024
- 79 Pages
North America
From €3080EUR$3,450USD£2,695GBP
- Report
- February 2024
- 83 Pages
Middle East, Africa
From €3080EUR$3,450USD£2,695GBP
- Report
- February 2024
- 95 Pages
Europe
From €3080EUR$3,450USD£2,695GBP
- Report
- February 2024
- 91 Pages
Asia Pacific
From €3080EUR$3,450USD£2,695GBP
- Report
- September 2023
- 173 Pages
Global
From €3973EUR$4,450USD£3,476GBP
- Report
- January 2021
- 245 Pages
Global
From €3214EUR$3,600USD£2,812GBP
- Report
- April 2023
- 99 Pages
North America
From €2634EUR$2,950USD£2,304GBP
- Report
- April 2023
- 95 Pages
From €2634EUR$2,950USD£2,304GBP
- Report
- April 2023
- 178 Pages
Global
From €4419EUR$4,950USD£3,866GBP
- Report
- January 2024
- 150 Pages
Global
From €3437EUR$3,850USD£3,007GBP
€4330EUR$4,850USD£3,788GBP
- Report
- October 2023
- 150 Pages
Global
From €3437EUR$3,850USD£3,007GBP
€4330EUR$4,850USD£3,788GBP
- Report
- December 2022
- 119 Pages
Global
From €4017EUR$4,500USD£3,515GBP
- Report
- October 2023
- 180 Pages
Global
From €2232EUR$2,500USD£1,953GBP
- Report
- July 2023
- 110 Pages
Global
From €4017EUR$4,500USD£3,515GBP
- Report
- August 2022
- 112 Pages
Global
From €4017EUR$4,500USD£3,515GBP
- Report
- April 2024
- 140 Pages
Global
From €4436EUR$4,969USD£3,881GBP
- Report
- November 2023
- 160 Pages
Global
From €3213EUR$3,599USD£2,811GBP
- Report
- October 2023
- 140 Pages
Global
From €3213EUR$3,599USD£2,811GBP
- Report
- September 2023
- 200 Pages
Global
From €3213EUR$3,599USD£2,811GBP
- Report
- June 2023
- 160 Pages
Global
From €4418EUR$4,949USD£3,865GBP

Macular Degeneration is a condition that affects the central part of the retina, known as the macula, which is responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50. Optical treatments for Macular Degeneration include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation is used to reduce the risk of further vision loss by sealing off leaking blood vessels in the macula. Photodynamic therapy is used to reduce the growth of abnormal blood vessels in the macula. Anti-VEGF injections are used to reduce the growth of abnormal blood vessels and improve vision.
Companies in the Macular Degeneration market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more